Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Immuron Ltd ADR (NQ: IMRN )

1.952 UNCHANGED
Streaming Delayed Price Updated: 2:39 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 1.952
Bid (Size) 1.680 (3)
Ask (Size) 2.570 (5)
Prev. Close 1.952
Today's Range 1.952 - 1.952
52wk Range 1.481 - 5.960
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why VF Corp Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket
Via Benzinga

Performance

YTD
+2.73%
+2.73%
1 Month
-27.44%
-27.44%
3 Month
-16.94%
-16.94%
6 Month
-22.70%
-22.70%
1 Year
+17.58%
+17.58%

More News

Read More
Immuron CEO, Steven Lydeamore participation in Maxim Virtual Healthcare Conference
From Immuron Limited
Via GlobeNewswire
Immuron Travelan® continued strong sales growth
From Immuron Limited
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
NMRC Reports Results for Campylobacter Controlled Human Infection Model Study
From Immuron Limited
Via GlobeNewswire
Immuron Plans Phase 2 Trial for IMM-529 following FDA review
From Immuron Limited
Via GlobeNewswire
Immuron Announces New U.S. Department of Defense Research Award for Naval Medical Research Command and Walter Reed Army Institute of Research to advance Travelan®
From Immuron Limited
Via GlobeNewswire
Immuron CEO, Steven Lydeamore to present at the Emerging Growth Conference
From Immuron Limited
Via GlobeNewswire
Immuron CEO, Steven Lydeamore to host webinar on MarketOpen Direct Connect
From Immuron Limited
Via GlobeNewswire
Immuron announces record Travelan® sales globally, Australia and USA
From Immuron Limited
Via GlobeNewswire
Immuron requests pre-IND meeting for IMM-529 with FDA filing
From Immuron Limited
Via GlobeNewswire
Immuron CEO, Steven Lydeamore to present at the Emerging Growth Conference
From Immuron Limited
Via GlobeNewswire
Immuron Board Changes
From Immuron Limited
Via GlobeNewswire
Immuron CEO Steven Lydeamore to present at Peak Sky High
From Immuron Limited
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Immuron Limited to Present at the Emerging Growth Conference
From Immuron Limited
Via GlobeNewswire
Immuron Director Resignation
From Immuron Limited
Via GlobeNewswire
Immuron to host Live Virtual Event
From Immuron Limited
Via GlobeNewswire
Why Ascent Solar Technologies Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Why PriceSmart Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Immuron Travelan® sales continued strong growth
From Immuron Limited
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Exposures Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.